Recent advances in the management of radiation colitis

Radiation colitis, an insidious, progressive disease of increasing frequency, develops 6 mo to 5 years after regional radiotherapy for malignancy, owing to the deleterious effects of the latter on the colon and the small intestine. When dealing with radiation colitis and its complications, the most conservative modality should be employed because the areas of intestinal injury do not tend to h…

Patient Diagnosis Resource for Radiation Colitis

Your doctor has determined that you have radiation colitis, an inflammation of the colon that occurs as a side effect of cancer radiation therapy to the abdomen or pelvis. The condition can arise from external radiation treatment delivered by a high energy X-ray machine or internal radiation therapy, which is delivered through small implants placed directly into or near the cancerous tumor

Comparative in-vitro activity of cefpirome againts isolates from intensive ca…

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-

Randomized comparative trial of cefpirome versus ceftazidime in the empirical…

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-

Comparison of Strategies Using Cefpirome and Ceftazidime for Empiric Treatmen…

In an international, multicenter, open-label, randomized comparative study, adult patients in intensive care units were enrolled to receive cefpirome intravenously at 2 g twice daily or ceftazidime intravenously at 2 g three times daily for the empiric treatment of pneumonia. Randomization was performed after a double stratification according to the investigator’s initial choice of monothe…

Cefpirome: a review of its antibacterial activity, pharmacokinetic properties…

Cefpirome is an injectable extended-spectrum or 'fourth generation ' cephalosporin. Its antibacterial activity encompasses many ofthe pathogens involved in hospital-acquired infections such as Enterobacteriaceae, methicillin-susceptible Staphylococcus aureus , coagulase-negative staphylococci and viridans group streptococci. Cefpirome also has in vitro activity against Streptococcus pneumoni…